Chi-Yu Kuo
Overview
Explore the profile of Chi-Yu Kuo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tsai C, Kuo C, Leu Y, Lee J, Cheng S
Updates Surg
. 2022 Oct;
75(1):209-216.
PMID: 36201137
While an increasing number of patients now undergo lobectomy for low-risk differentiated thyroid cancer, a subset of patients require completion thyroidectomy to facilitate radioactive iodine therapy. Completion thyroidectomy is generally...
12.
Huang S, Tsai C, Kuo C, Li Y, Cheng S
Endocrine
. 2022 Jun;
78(1):85-94.
PMID: 35761130
Purpose: ATP-citrate lyase (ACLY) is a critical enzyme at the intersection of glucose and lipid metabolism. ACLY is often upregulated or activated in cancer cells to accelerate lipid synthesis and...
13.
Lee F, Kuo C, Tsai C, Cheng S
Curr Issues Mol Biol
. 2022 Jun;
44(4):1488-1496.
PMID: 35723359
Sodium iodide symporter (NIS) expression in thyroid follicular cells plays an important role in normal physiology and radioactive iodine therapy for thyroid cancer. Loss of NIS expression is often seen...
14.
Lin W, Wang C, Wang W, Kuo C, Chiang P, Lin A, et al.
J Pers Med
. 2022 Jan;
12(1).
PMID: 35055378
Background: To evaluate the effectiveness and safety of radiofrequency ablation (RFA) treatment for benign thyroid nodules (BTNs) in five medical centers in Taiwan. Methods: From April 2016 to July 2020,...
15.
Kuo C, Chang Y, Chien M, Jhuang J, Hsu Y, Huang S, et al.
Endocr Relat Cancer
. 2021 Nov;
29(2):47-58.
PMID: 34821220
Aberrant lipid metabolism provides bioenergetic, biosynthetic, and redox supplies to cancer cells. Previous studies have reported differential lipid profiling in thyroid malignancies. Sterol regulatory element-binding protein 1 (SREBP1), encoded by...
16.
Kuo C, Liu C, Tsai C, Cheng S
Int J Hyperthermia
. 2021 Nov;
38(1):1536-1540.
PMID: 34727824
Background: Radiofrequency ablation (RFA) has been increasingly accepted as an alternative to surgery in the treatment of symptomatic benign thyroid nodules. However, the learning curve of thyroid RFA has yet...
17.
Kuo C, Wu M, Ko W, Cheng S
World J Surg
. 2021 Oct;
46(1):112-120.
PMID: 34608544
Aim: Radiofrequency ablation (RFA) is a relatively safe and efficient alternative to surgery for patients with benign thyroid nodules. We investigated predictive factors associated with volume reduction using digital imaging...
18.
Kuo C, Yang P, Chien M, Cheng S
Eur Thyroid J
. 2020 Oct;
9(5):256-262.
PMID: 33088794
Objective: Extrathyroidal extension may not be accurately recognized during thyroidectomy and can increase the risk of positive margins and even recurrence. This study aimed to investigate the preoperative factors associated...
19.
Cheng S, Lee J, Chien M, Kuo C, Jhuang J, Liu C
Eur J Surg Oncol
. 2020 Aug;
46(10 Pt A):1814-1819.
PMID: 32732093
Introduction: Lymphovascular invasion (LVI) is associated with disease recurrence and compromised survival in patients with thyroid cancer. Nonetheless, LVI is not identifiable on preoperative ultrasound or cytologic assessment. We aimed...
20.
Tsai C, Yang P, Lee J, Liu T, Kuo C, Cheng S
Otolaryngol Head Neck Surg
. 2019 Feb;
160(6):993-1002.
PMID: 30721111
Objective: The current guidelines recommend that potassium iodide be given in the immediate preoperative period for patients with Graves' disease who are undergoing thyroidectomy. Nonetheless, the evidence behind this recommendation...